Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingbing Wang

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Academic Radiology|September 4, 2022
Key Factors to Attract More U.S. Diagnostic Radiology Residents into the Field of Nuclear Medicine and Molecular Imaging: A National SurveyBashar Kako, Jian W Dong, Brian P An, et al.
Neurocase|July 2, 2026
Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemabNicholas U Schwartz, Connor D Dietz, Zoe Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing ChemoradiationBrent S Rose, Kyung-Wook Jee, Andrzej Niemierko, et al.
Academic Radiology|August 15, 2024
Evaluating the Added Value of Concurrent Contrast-enhanced Diagnostic CT for PSMA-PET/CT InterpretationKelly Trinh, David Z Chow, Hyesun Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
<sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent TrialsYingbing Wang, Karen L Ayres, Debra A Goldman, et al.
Neurology. Clinical Practice|June 30, 2025
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer DiseaseNicholas U Schwartz, Connor D Dietz, Igor Prufer Araújo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2025
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performanceIgor Prufer Q C Araujo, Tara Ellingson, Nicholas U Schwartz, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19Michael J Peluso, Dylan Ryder, Robert Flavell, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration ApprovalAbuzar Moradi Tuchayi, Surekha Yadav, Fei Jiang, et al.
Academic Radiology|September 4, 2022
Key Factors to Attract More U.S. Diagnostic Radiology Residents into the Field of Nuclear Medicine and Molecular Imaging: A National SurveyBashar Kako, Jian W Dong, Brian P An, et al.
Neurocase|July 2, 2026
Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemabNicholas U Schwartz, Connor D Dietz, Zoe Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing ChemoradiationBrent S Rose, Kyung-Wook Jee, Andrzej Niemierko, et al.
Academic Radiology|August 15, 2024
Evaluating the Added Value of Concurrent Contrast-enhanced Diagnostic CT for PSMA-PET/CT InterpretationKelly Trinh, David Z Chow, Hyesun Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
<sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent TrialsYingbing Wang, Karen L Ayres, Debra A Goldman, et al.
Neurology. Clinical Practice|June 30, 2025
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer DiseaseNicholas U Schwartz, Connor D Dietz, Igor Prufer Araújo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2025
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performanceIgor Prufer Q C Araujo, Tara Ellingson, Nicholas U Schwartz, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19Michael J Peluso, Dylan Ryder, Robert Flavell, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
Pageof 3